EIGER BIOPHARMACEUTICALS INC

Profile

Company Names

EIGER BIOPHARMACEUTICALS INC

Addresses

350 CAMBRIDGE AVENUE, SUITE 350, PALO ALTO, CA 94306

1115 LAFAYETTE ST, SANTA CLARA, CA 95050

1115 LAFAYETTE ST., SUITE 336, SANTA CLARA, CA 95050

1115 LAFAYETTE ST., SANTA CLARA, CA 95050

3350 W. BAYSHORE ROAD, SUITE 120, PALO ALTO, CA 94303

Phone Numbers

650-272-6138
650-804-8553
(415) 203-0934
(650)320-9900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$28,762,851.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-11-12 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
2
2011-04-15 
$14,462,851.00 
$14,603,554.00 
$140,703.00 
Equity 
1
2008-12-10 
$8,300,000.00 
$8,300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
CORY 
EXECUTIVE OFFICER, DIRECTOR
EIGER BIOPHARMACEUTICALS INC   |  CASI PHARMACEUTICALS, INC.
THOMAS 
 
DIETZ 
DIRECTOR
VIROBAY INC   |  AGBIOME, LLC   |  EIGER BIOPHARMACEUTICALS INC   |  LEAP THERAPEUTICS, INC.
ED 
 
ENGLEMAN 
DIRECTOR
EIGER BIOPHARMACEUTICALS INC
JEFFREY 
 
GLENN 
DIRECTOR
EIGER BIOPHARMACEUTICALS INC   |  PATH LABS HOLDINGS, LLC
NINA 
 
KJELLSON 
DIRECTOR
LYCERA CORP   |  PRIMERA BIOSYSTEMS INC   |  PRIMERADX, INC.   |  ALVINE PHARMACEUTICALS INC   |  SEQUEL PHARMACEUTICALS INC   |  CNS THERAPEUTICS INC   |  TRIUS THERAPEUTICS INC   |  CEBIX INCOPRATED   |  CEBIX INC   |  EIGER BIOPHARMACEUTICALS INC   |  OCERA THERAPEUTICS INC   |  WELLTOK, INC.   |  OCERA THERAPEUTICS, INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  ANNUM HEALTH, INC.   |  VINETI, INC.   |  TYRA BIOSCIENCES, INC.
GLEN 
 
SATO 
EXECUTIVE OFFICER
ACUCELA INC   |  INTARCIA THERAPEUTICS, INC   |  EIGER BIOPHARMACEUTICALS INC   |  ALTHEOS, INC.   |  BULLET BIOTECHNOLOGY, INC.
PAUL 
 
TRUEX 
DIRECTOR
TRIUS THERAPEUTICS INC   |  EIGER BIOPHARMACEUTICALS INC   |  MILESTONE PHARMACEUTICALS INC.
KEITH 
 
VENDOLA 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS INC   |  REZOLUTE, INC.   |  WUGEN, INC.
WENJIN 
 
YANG 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS INC   |  ALDEA PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-11-12 
2015-03-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2015-02-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2014-11-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2014-09-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2014-04-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2013-05-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2012-08-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2011-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2010-09-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-12-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#